MedTrace Logo

The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices

NCT03502811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1041

Last updated 2022-02-16

Study results available
· View outcomes & findings →

Summary

The MitraClip EXPAND Study (A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip Devices) is designed to confirm the safety and performance of the MitraClip NTR System and MitraClip XTR System.

Conditions

  • Mitral Valve Regurgitation
  • Mitral Regurgitation

Interventions

DEVICE

MitraClip NTR/XTR System

Percutaneous mitral valve repair using the MitraClip NTR/XTR system.

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Dr. Saibal Kar, MD · Cedars Sinai, Los Angeles CA

  • Prof. Francesco Maisano, MD · University Hospital, Zürich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-26
Primary Completion
2019-04-05
Completion
2020-12-31

Countries

  • United States
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03502811 on ClinicalTrials.gov